Publication Type : Journal Article
Publisher : Journal of pharmacology & pharmacotherapeutics
Source : Journal of pharmacology & pharmacotherapeutics, Volume 2, p.287-9 (2011)
Url : https://www.researchgate.net/publication/51743938_Effect_of_silymarin_in_diabetes_mellitus_patients_with_liver_diseases
Campus : Kochi
School : School of Pharmacy
Department : Pharmacy Practice
Year : 2011
Abstract : Previous studies have reported that silymarin reduces hepatic fibrosis via TGF-b1 and is associated with inhibiting glycogenolysis and gluconeogenesis through inactivation of the intrahepatic NF-kB signaling pathway (Jose et al., 2011). In the present study, we found that silymarin downregulated blood glucose level and significantly improved cardiac dysfunction in STZ-induced diabetic rats.
Cite this Research Publication : M. Jose, Abraham, A., and Dr. M.P.Narmadha, “Effect of silymarin in diabetes mellitus patients with liver diseases”, Journal of pharmacology & pharmacotherapeutics, vol. 2, pp. 287-9, 2011.